ELRIG has announced Dr Stephen Ward and Dr Annarita Miccio as keynote speakers for its Cell and Gene Therapy event in March. 

The not-for-profit organisation aims to bring together leading scientists, economists and patient advocates to explore breakthroughs shaping the future of medicine.  

The programme, focussing on translational impact and patient perspectives, includes talks and poster presentations covering neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy.  

Ward joins the event with over two decades of cell and gene therapy expertise, within a career spanning biological medicine research, development and manufacturing. He has been with the Cell and Gene Therapy Catapult for over 10 years and, in 2024, he became Chief Technology Officer, shaping the organisation’s technology development strategy.  

 Miccio directs the laboratory of chromatin and gene regulation during development at the Imagine Institute in Paris, France. Her work focusses on transcriptional control of haematopoiesis and developing therapies for beta–haemoglobinopathies. Miccio optimised the design of lentiviral vectors currently employed in a clinical trial for sickle cell disease and developed CRISPR/Cas9 strategies for beta-haemoglobinopathies.  

“We have curated a programme that combines cutting-edge talks, interactive panel discussions, and dedicated networking opportunities to foster collective progress and spark new ideas,” said Dr David Baker, Associate Director of AstraZeneca and ELRIG’s Conference Director. 

“Drs Ward and Miccio are both renowned leaders in cell and gene therapy and we are privileged to have them on board as keynote speakers to share their perspectives and expertise. We look forward to welcoming scientists from academia and industry, patient advocates, investors and policy makers to be part of the conversation that will define the next era of cell and gene therapy.” 

The event will take place on 9 and 10 March at Hinxton Hall in Cambridge, UK. 

 

Bruno Quinney, Content Team, DDW